Search results with tag "Myeloma group"

Oxford Myeloma Group

1.0 mg/m2 S/C bolus “”Only where bortezomib is indicated”” * It is reasonable to consider capping at BSA of 2 m2 in selected patients CYCLE FREQUENCY Cycle length: 4-6 weeks. Total number of cycles 2-4. Thalidomide can be omitted on clinician’s discretion if disease is assessed to be Thalidomide resistant. DOSE MODIFICATIONS ...

  Group, Myeloma, Clinician, Myeloma group